On Demand
Keystone Symposia ePanel:
Chewing the Fat: Panel and Discussion about Autophagy and Future Directions of the Autophagy Field
This panel discussion occurred during the "Autophagy: Molecular and Physiological Mechanisms" Keystone Symposia conference in Whistler, British Columbia, Canada on June 7, 2016. Eric Baehrecke, Ana Maria Cuervo, Vojo Deretic and Leon Murphy met to discuss their interests in autophagy. Topics included some history, current and future areas of research focus, controversies, and speculation about the future directions of the autophagy field.
___
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Moderator
Eric H. Baehrecke, PhDUniversity of Massachusetts Medical SchoolPanelists
Ana Maria Cuevo, MD, PhDAlbert Einstein College of MedicineVojo Deretic, PhDUniversity of New Mexico Health Sciences CenterLeon O. Murphy, PhDCasma TherapeuticsFreeStandard Price
Keystone Symposia ePanel:
Autophagy: Controversies, Challenges & Opportunities
Recorded during Keystone Symposia meeting: Autophagy [E615]
Date: June 19 - 24, 2015
Location: Beaver Run Resort, Breckenridge, CO
___
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Moderator
Eric H. Baehrecke, PhDUniversity of Massachusetts Medical SchoolPanelists
Ana Maria Cuevo, MD, PhDAlbert Einstein College of MedicineVojo Deretic, PhDUniversity of New Mexico Health Sciences CenterLeon O. Murphy, PhDCasma TherapeuticsFreeStandard Price
Keystone Symposia SciTalks:
Determinants of viral control following ART-interruption in SIV-infected macaques
Recorded: March 20 - 24, 2016
Keystone Symposia meeting: HIV Vaccines [X8]
Location: Resort at Squaw Creek, Olympic Valley, CA
___
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Speaker
Luca Micci, PhDYerkes National Primate Research Center (YNPRC), Emory UniversityFreeStandard Price
Keystone Symposia SciTalks:
Optimal Combinations of Broadly Neutralizing Antibodies for Prevention & Therapy of HIV-1 Clade C Infection
Recorded: March 20 - 24, 2016
Keystone Symposia meeting: HIV Vaccines [X8]
Location: Resort at Squaw Creek, Olympic Valley, CA
___
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Speaker
Kshitij Wagh, PhDLos Alamos National LaboratoryFreeStandard Price
Keystone Symposia SciTalks:
A novel conserved-region T-cell mosaic vaccine with very globale coverage of HIV-1 variants is recognized by protective responses in chronic untreated infection
Recorded: March 20 - 24, 2016
Keystone Symposia meeting: HIV Vaccines [X8]
Location: Resort at Squaw Creek, Olympic Valley, CA
___
Copyright Keystone Symposia, 2017. All rights reserved.
About Keystone Symposia:
Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.
Website: www.keystonesymposia.org
Speaker
Tomas Hanke, PhDUniversity of OxfordFreeStandard Price
Keystone Symposia Live Panel:The Genome Editing Revolution: Translating Genome Editing Technologies into Human TherapiesRecent advances in genome editing nucleases have led to their broader application in biomedical research and dramatically accelerated efforts to develop therapeutics based on this technology. In this dynamic, interactive panel event, experts in genome editing and gene therapy from academia and industry will discuss the following topics and others relevant to clinical translation of the technology:
- What are the most important recent basic science and technological advances and biggest impacts in the field of genome editing that will substantially advance the prospects of gene-based therapy?
- How can the experiences of the gene therapy field inform the development of genome editing therapeutics?
- What are the risks and biggest obstacles that must be minimized and overcome to successfully translate genome editing into human therapeutics?
- Which diseases are the most promising candidates to benefit from genome editing therapies?
- What impact, if any, has the CRISPR IP dispute had on developing gene-based therapeutics?
___Copyright Keystone Symposia, 2017. All rights reserved.About Keystone Symposia:Keystone Symposia is a 501(c)(3) nonprofit organization founded in 1972 that convenes 50-60 open, international scientific research conferences each year across the full range of the life sciences – from cardiovascular disease to immunology to neurobiology. The conferences accelerate life science discovery by bringing together and fostering collaboration among the world’s leading and next generation of research scientists.Website: www.keystonesymposia.org
Moderator
J. Keith Joung, MD, Ph.D.Massachussetts General HospitalPanelists
Rachel E. Haurwitz, PhDCaribou Biosciences, Inc.Michael Holmes, PhDSangamoAlexandra Glucksmann, PhDEditas MedicineJames M. Wilson, MD, PhDUniversity of Pennsylvania, Perelman School of MedicineFreeStandard Price
Recorded on February 19, 2017
Pre Meeting Workshop
Malaria: From Innovation to Eradication
Feb 19 - Feb 23, 2017 | Kampala, Uganda
View and Download Presentation
This Keystone Symposia SciTalk was made possible by a grant from the
The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.
Speaker
Krijn Paaijmans, PhDISGlobal, Barcelona Institute for Global HealthFreeStandard Price
Recorded on May 22, 2016
Pre Meeting Workshop
Vaccines for Tropical Diseases
May 22 - May 26, 2016 | Cape Town , South Africa
The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.
This Keystone Symposia SciTalk was made possible by a grant from the
Speaker
Vish Nene, PhDInternational Livestock Research InstituteFreeStandard Price
Recorded on March 26, 2017
Pre Meeting Workshop
HIV VACCINES
March 26 - March 30, 2017
Steamboat Springs, Colorado, USA
This Keystone Symposia SciTalk was made possible by a grant from the
The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.
Speaker
Andrew B. Ward, PhDThe Scripps Research InstituteFreeStandard Price
Recorded on March 26, 2017
Pre Meeting Workshop
HIV VACCINES
March 26 - March 30, 2017
Steamboat Springs, Colorado, USA
This Keystone Symposia SciTalk was made possible by a grant from the
The goal of the pre meeting workshop is to provide valuable background on what to expect for the upcoming Keystone Symposia. The intent is to bring participants up to speed on the concepts to be presented at the meeting and enable the them to maximize their experience.
Recorded on March 26, 2017
Speaker
Elise Landais, PhDIAVI Neutralizing antibody CenterFreeStandard Price![Thumbnail for Engineering Adoptive T Cell Therapy for Efficacy in Ovarian Cancer [SHORT TALK]](https://assets.prod.dp.digitellcdn.com/api/services/imgopt/mw_400,mh_400/akamai-opus-nc-public.digitellcdn.com/assets/img/ks/product_icons/1099.jpg.webp)
Recorded during the Keystone Symposia meeting:
Cancer Immunology and Immunotherapy: Taking a Place in Mainstream Oncology
Mar 19 - Mar 23, 2017 | Whistler, British Columbia, Canada
Speaker
Kristin Anderson, PhDUniversity of WashingtonFreeStandard Price
Developing a collaborative network to study TB and HIV biomarkers
Dr. Andrade lab is dedicated to identifying reliable host biomarkers that can predict susceptibility to infection and disease severity in tuberculosis (TB) and HIV. By establishing a strong network of collaborators from different TB endemic countries, such as India, China, South Africa and Brazil, his group has designed cohort studies in which synchronization of clinical and immunologic data collection results in validation of biomarker findings across countries. In addition, the Andrade Lab performs integrative analyses merging epidemiologic, socioeconomic, clinical, immunologic, microbiologic and geographic data to more robustly describe the TB determinants and help to delineate more reliable decision-making strategies.Speaker
Bruno B. Andrade, MD, PhDOswaldo Cruz Foundation (FIOCRUZ)
In silico B-cell epitope prediction: developing differential diagnosis for haemorraghic diseases caused by orthohantaviruses
Orthohantaviruses are the etiological agents of serious rodent-borne neglected human diseases named as hemorrhagic fever with renal syndrome (HFRS) and orthohantavirus cardiopulmonary syndrome (HCPS). These distinct clinical manifestations of disease are related to specific orthohantavirus species and it is believed that HFRS-associated orthohantavirus mainly circulate into Old World (Asia and Europe) whereas HCPS-associated orthohantaviruses are predominant into New World countries (Americas). However, since Seoul orthohantavirus, associated with HFRS, was isolated in America and its natural host (Rattus norvegicus) are widely distributed around the world, it raised the question if the viral underreporting is associated to lower medical awareness of the symptoms or if it is associated to misdiagnosis with other tropical hemorrhagic diseases (leptospirosis, yellow fever). In this context, considering that the HFRS are clinically indistinguishable from order hemorrhagic diseases, and that serological tests are predominantly based on serology tests against nucleoprotein, a highly conserved protein among different orthohantavirus, we hypothesize that current available tests do not detect all HFRS-associated orthohantavirus. In this sense; we aimed to identify B-cell linear epitopes exclusively conserved on HFRS-associated orthohantavirus nucleoprotein, using a combination of in silico and experimental approaches, to identify targets that could be applied in the development of novel immunodiagnostic tools able to identify different HFRS orthohantavirus species.Speaker
Oswaldo Cruz Foundation (FIOCRUZ)
